vs

Side-by-side financial comparison of Omega Flex, Inc. (OFLX) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

RECURSION PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($35.5M vs $25.2M, roughly 1.4× Omega Flex, Inc.). Omega Flex, Inc. runs the higher net margin — 13.5% vs -304.2%, a 317.8% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs -6.5%). Omega Flex, Inc. produced more free cash flow last quarter ($7.3M vs $-47.3M). Over the past eight quarters, RECURSION PHARMACEUTICALS, INC.'s revenue compounded faster (60.5% CAGR vs -0.0%).

Smart Omega Esports, formerly known as PLDT–Smart Omega, is a Philippine franchise-based professional esports team which competes in The Nationals, the top esports league in the Philippines sanctioned by the eSports National Association of the Philippines, and MPL Philippines. It was formed as a result of a partnership between esports team Sterling Global Dragons and corporate firms, PLDT Inc. and its mobile arm, Smart Communications.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

OFLX vs RXRX — Head-to-Head

Bigger by revenue
RXRX
RXRX
1.4× larger
RXRX
$35.5M
$25.2M
OFLX
Growing faster (revenue YoY)
RXRX
RXRX
+688.3% gap
RXRX
681.7%
-6.5%
OFLX
Higher net margin
OFLX
OFLX
317.8% more per $
OFLX
13.5%
-304.2%
RXRX
More free cash flow
OFLX
OFLX
$54.6M more FCF
OFLX
$7.3M
$-47.3M
RXRX
Faster 2-yr revenue CAGR
RXRX
RXRX
Annualised
RXRX
60.5%
-0.0%
OFLX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OFLX
OFLX
RXRX
RXRX
Revenue
$25.2M
$35.5M
Net Profit
$3.4M
$-108.1M
Gross Margin
59.2%
59.8%
Operating Margin
15.8%
-304.8%
Net Margin
13.5%
-304.2%
Revenue YoY
-6.5%
681.7%
Net Profit YoY
-27.1%
39.6%
EPS (diluted)
$0.34
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OFLX
OFLX
RXRX
RXRX
Q4 25
$25.2M
$35.5M
Q3 25
$24.2M
$5.2M
Q2 25
$25.5M
$19.2M
Q1 25
$23.3M
$14.7M
Q4 24
$27.0M
$4.5M
Q3 24
$24.9M
$26.1M
Q2 24
$24.6M
$14.4M
Q1 24
$25.2M
$13.8M
Net Profit
OFLX
OFLX
RXRX
RXRX
Q4 25
$3.4M
$-108.1M
Q3 25
$3.7M
$-162.3M
Q2 25
$4.2M
$-171.9M
Q1 25
$3.6M
$-202.5M
Q4 24
$4.7M
$-178.9M
Q3 24
$4.6M
$-95.8M
Q2 24
$4.5M
$-97.5M
Q1 24
$4.2M
$-91.4M
Gross Margin
OFLX
OFLX
RXRX
RXRX
Q4 25
59.2%
59.8%
Q3 25
60.2%
-183.8%
Q2 25
60.4%
-4.9%
Q1 25
60.3%
-48.0%
Q4 24
61.5%
-181.4%
Q3 24
61.7%
53.7%
Q2 24
61.8%
36.2%
Q1 24
59.9%
19.1%
Operating Margin
OFLX
OFLX
RXRX
RXRX
Q4 25
15.8%
-304.8%
Q3 25
17.3%
-3327.6%
Q2 25
18.5%
-916.8%
Q1 25
17.4%
-1297.9%
Q4 24
21.4%
-4042.4%
Q3 24
22.0%
-377.1%
Q2 24
21.5%
-697.4%
Q1 24
20.1%
-698.4%
Net Margin
OFLX
OFLX
RXRX
RXRX
Q4 25
13.5%
-304.2%
Q3 25
15.2%
-3135.3%
Q2 25
16.3%
-894.2%
Q1 25
15.3%
-1373.3%
Q4 24
17.4%
-3935.5%
Q3 24
18.6%
-367.5%
Q2 24
18.3%
-676.6%
Q1 24
16.7%
-662.4%
EPS (diluted)
OFLX
OFLX
RXRX
RXRX
Q4 25
$0.34
$-0.17
Q3 25
$0.37
$-0.36
Q2 25
$0.41
$-0.41
Q1 25
$0.35
$-0.50
Q4 24
$0.45
$-0.56
Q3 24
$0.46
$-0.34
Q2 24
$0.45
$-0.40
Q1 24
$0.42
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OFLX
OFLX
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$53.2M
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$84.2M
$1.1B
Total Assets
$105.0M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OFLX
OFLX
RXRX
RXRX
Q4 25
$53.2M
$743.3M
Q3 25
$49.4M
$659.8M
Q2 25
$50.7M
$525.1M
Q1 25
$49.2M
$500.5M
Q4 24
$51.7M
$594.4M
Q3 24
$45.9M
$427.6M
Q2 24
$45.7M
$474.3M
Q1 24
$45.3M
$296.3M
Total Debt
OFLX
OFLX
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
OFLX
OFLX
RXRX
RXRX
Q4 25
$84.2M
$1.1B
Q3 25
$84.2M
$1.0B
Q2 25
$84.0M
$919.1M
Q1 25
$83.3M
$933.9M
Q4 24
$83.1M
$1.0B
Q3 24
$82.0M
$524.6M
Q2 24
$80.6M
$584.4M
Q1 24
$79.6M
$401.2M
Total Assets
OFLX
OFLX
RXRX
RXRX
Q4 25
$105.0M
$1.5B
Q3 25
$103.8M
$1.4B
Q2 25
$102.8M
$1.3B
Q1 25
$102.8M
$1.3B
Q4 24
$105.9M
$1.4B
Q3 24
$102.9M
$726.5M
Q2 24
$99.6M
$775.9M
Q1 24
$99.2M
$557.8M
Debt / Equity
OFLX
OFLX
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OFLX
OFLX
RXRX
RXRX
Operating Cash FlowLast quarter
$7.5M
$-46.1M
Free Cash FlowOCF − Capex
$7.3M
$-47.3M
FCF MarginFCF / Revenue
28.9%
-133.1%
Capex IntensityCapex / Revenue
0.8%
3.5%
Cash ConversionOCF / Net Profit
2.20×
TTM Free Cash FlowTrailing 4 quarters
$15.4M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OFLX
OFLX
RXRX
RXRX
Q4 25
$7.5M
$-46.1M
Q3 25
$2.7M
$-117.4M
Q2 25
$5.5M
$-76.4M
Q1 25
$1.6M
$-132.0M
Q4 24
$9.8M
$-115.4M
Q3 24
$4.0M
$-59.2M
Q2 24
$4.4M
$-82.2M
Q1 24
$2.7M
$-102.3M
Free Cash Flow
OFLX
OFLX
RXRX
RXRX
Q4 25
$7.3M
$-47.3M
Q3 25
$2.0M
$-117.6M
Q2 25
$5.0M
$-79.6M
Q1 25
$1.0M
$-133.8M
Q4 24
$9.2M
$-116.7M
Q3 24
$3.6M
$-63.8M
Q2 24
$3.8M
$-83.4M
Q1 24
$2.2M
$-109.0M
FCF Margin
OFLX
OFLX
RXRX
RXRX
Q4 25
28.9%
-133.1%
Q3 25
8.4%
-2272.5%
Q2 25
19.6%
-413.9%
Q1 25
4.3%
-907.4%
Q4 24
34.1%
-2567.7%
Q3 24
14.7%
-244.6%
Q2 24
15.3%
-578.5%
Q1 24
8.9%
-789.9%
Capex Intensity
OFLX
OFLX
RXRX
RXRX
Q4 25
0.8%
3.5%
Q3 25
2.5%
4.7%
Q2 25
1.7%
16.4%
Q1 25
2.4%
12.4%
Q4 24
2.1%
28.6%
Q3 24
1.4%
17.5%
Q2 24
2.6%
8.2%
Q1 24
1.8%
48.2%
Cash Conversion
OFLX
OFLX
RXRX
RXRX
Q4 25
2.20×
Q3 25
0.72×
Q2 25
1.31×
Q1 25
0.44×
Q4 24
2.08×
Q3 24
0.86×
Q2 24
0.98×
Q1 24
0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons